Mortality after a cerebrovascular event in age‐related macular degeneration patients treated with bevacizumab ocular injections.

MLA

Hanhart, Joel, et al. “Mortality after a Cerebrovascular Event in Age‐related Macular Degeneration Patients Treated with Bevacizumab Ocular Injections.” Acta Ophthalmologica (1755375X), vol. 96, no. 6, Sept. 2018, pp. e732–39. EBSCOhost, https://doi.org/10.1111/aos.13731.

APA

Hanhart, J., Comaneshter, D. S., & Vinker, S. (2018). Mortality after a cerebrovascular event in age‐related macular degeneration patients treated with bevacizumab ocular injections. Acta Ophthalmologica (1755375X), 96(6), e732–e739. https://doi.org/10.1111/aos.13731

Chicago

Hanhart, Joel, Doron S. Comaneshter, and Shlomo Vinker. 2018. “Mortality after a Cerebrovascular Event in Age‐related Macular Degeneration Patients Treated with Bevacizumab Ocular Injections.” Acta Ophthalmologica (1755375X) 96 (6): e732–39. doi:10.1111/aos.13731.